These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 4394192)

  • 41. [Analysis of the systolic phase of the left ventricle in assessing the efficacy of therapy of patients with chronic coronary insufficiency].
    Shmeleva NK
    Ter Arkh; 1966 Sep; 38(9):77-81. PubMed ID: 4385082
    [No Abstract]   [Full Text] [Related]  

  • 42. [Clinical experiences with treating coronary artery disease with adrenergic beta receptor blockaders].
    Szulc EJ
    Wiad Lek; 1972 Dec; 25(23):2093-7. PubMed ID: 4405150
    [No Abstract]   [Full Text] [Related]  

  • 43. [Drug lowering of the HDL concentration in the serum of cardiologically treated patients].
    Köhler P; Baufeld H; Stöckel A; Ziegenhorn A
    Z Gesamte Inn Med; 1982 Oct; 37(19):654-8. PubMed ID: 6129752
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [Experience with the coronary therapeutic agent STENO-Tromcardin in the general practice].
    Jaschke J
    Med Welt; 1969 Mar; 13():744-6. PubMed ID: 5784357
    [No Abstract]   [Full Text] [Related]  

  • 45. [Clinical experience with preparation LB-46 in various rhythm disorders and ischemic heart disease].
    De La Hoz Fabra J; Pérez Casar F; Carillo Kabana J
    Rev Esp Cardiol; 1970; 23(1):76-99. PubMed ID: 4393269
    [No Abstract]   [Full Text] [Related]  

  • 46. [Therapy and prevention of ischemic heart diseases].
    Gill E
    Z Allgemeinmed; 1973 Oct; 49(28):1354-6. PubMed ID: 4756675
    [No Abstract]   [Full Text] [Related]  

  • 47. [Changes in the electrocardiographic pattern after exercise in patients with coronary disease following administration of beta-blocking agents].
    Sala G; Foresti A; Campolo L
    Minerva Cardioangiol; 1969 Oct; 17(10):759-67. PubMed ID: 4396845
    [No Abstract]   [Full Text] [Related]  

  • 48. [Atherosclerosis progression and standard in coronary disease. Nitrate with special talents: PETN (pentaerythritol tetranitrate) is vasoprotective].
    MMW Fortschr Med; 2002 Nov; 144(45):51. PubMed ID: 12534064
    [No Abstract]   [Full Text] [Related]  

  • 49. [Protective effect of a beta-blockador on clinico-electrocardiographic manifestations in the coronary insufficiency apparent during Master's test: description of a clinical case].
    Conti G; Piemontese M; Savarese A; Valva M
    Clin Ter; 1969 Apr; 49(2):181-7. PubMed ID: 4401859
    [No Abstract]   [Full Text] [Related]  

  • 50. [Evaluation of the clinical effects of a beta-adrenergic blocking agent: butydrine].
    Bianchi G; Guzalian A; Cerri B
    Minerva Cardioangiol; 1968 Oct; 16(10):982-6. PubMed ID: 5727893
    [No Abstract]   [Full Text] [Related]  

  • 51. [Clinical evaluation of the beta-adrenergic blocking action of butydrine].
    Nigro G; Comi LI; Limongelli F
    Minerva Cardioangiol; 1968 Dec; 16(12):1267-72. PubMed ID: 5752613
    [No Abstract]   [Full Text] [Related]  

  • 52. [Use of alprenolol in coronary disease].
    Tricot R; Valère PE
    Ann Med Interne (Paris); 1971 Feb; 122(2):233-6. PubMed ID: 4397123
    [No Abstract]   [Full Text] [Related]  

  • 53. [On the circulatory effect of the coronary dilator PETN].
    Tilsner V
    Med Klin; 1969 Jun; 64(24):1120-3. PubMed ID: 5809489
    [No Abstract]   [Full Text] [Related]  

  • 54. The effect of a new beta blocking drug (butidrine) on some biohumoral indices, liver and kidney function and exercise tolerance.
    Barbi G; Tallone B
    Panminerva Med; 1969; 11(7):372-7. PubMed ID: 4390702
    [No Abstract]   [Full Text] [Related]  

  • 55. [Immediate effect of beta-blockaders on coronary patients during exertion].
    Vastesaeger MM; Rasson G
    Brux Med; 1971 Jun; 51(6):429-36. PubMed ID: 4397872
    [No Abstract]   [Full Text] [Related]  

  • 56. Medical perspectives of coronary artery disease.
    Russek HI
    Angiology; 1967 Jan; 18(1):15-22. PubMed ID: 4959655
    [No Abstract]   [Full Text] [Related]  

  • 57. [Coronary vasodilators in surgery].
    Mijangos Lazcano D
    Rev Med Hosp Gen (Mex); 1965 Mar; 28(3):219-24. PubMed ID: 5829934
    [No Abstract]   [Full Text] [Related]  

  • 58. [Clinical effect of beta receptor blockader in angina pectoris caused by coronary sclerosis].
    Schaller K
    Z Arztl Fortbild (Jena); 1970 Jul; 64(13):671-3. PubMed ID: 4398819
    [No Abstract]   [Full Text] [Related]  

  • 59. [Effect of pentaerithrol and raupasil on nasal patency].
    Kubiak S; Hauslinger J
    Pol Tyg Lek; 1977 Jan; 32(2):57-9. PubMed ID: 834635
    [No Abstract]   [Full Text] [Related]  

  • 60. [Data on the effects of butydrine in patients with coronary insufficiency].
    De Maestri C; Rinaldi AR
    Minerva Cardioangiol; 1969 Feb; 17(2):142-50. PubMed ID: 5777638
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.